Self-cleaning surfaces: just add daylight
Technology used widely in Japan to keep buildings and streets spotless is now available in Europe and is expected to find wide applications in new construction materials and road furniture.
We publish news of technology innovations, investment opportunities, together with updates from spinout & startup companies and licensees
Technology used widely in Japan to keep buildings and streets spotless is now available in Europe and is expected to find wide applications in new construction materials and road furniture.
In a major move to exploit its innovative location monitoring technology, OxLoc Ltd, an Oxford University spin-out company, has chosen to partner with the leading European animal tracking company Televilt.
MindWeavers set to launch new products for Brain Health market.
Rockstar Games confirmed in June 2007 that it is using euphoria technology from NaturalMotion Ltd in the computer game Grand Theft Auto IV, due for release in late 2007. The Grand Theft Auto franchise is one of the best-selling of all games titles.
The OxLoc asset alert, a self contained, long life, battery powered GPS/GSM tracking device has been used by one of OxLoc’s customers to successfully recover two vehicles stolen from his fleet.
In June 2007 Oxford University spun out a new company called Clinox from the Department of Clinical Pharmacology. Clinox offers pharmaceutical and biotechnology companies knowledge and expertise in the development, placement and conduct of early phase clinical trials with a particular focus in oncology.
Over 100 representatives from the business, technology, research and investment communities in Oxfordshire and beyond gathered at the Said Business School last night as the winners of the Martin and Audrey Wood Enterprise Awards 2007 were chosen.
A technique which enabled light microscopy to produce an in-focus image of a three-dimensional structure at all depths would be extremely valuable.
In September 2006 I arrived from Valencia. I came to Oxford to work at Oxford University Innovation Ltd as a ‘secondee’ for six months.
In March 2006 Geron Corporation entered into a worldwide exclusive licence agreement covering patent applications describing a method for generating dendritic cells from human embryonic stem cells. In a linked research agreement, Geron will fund work in the University’s Sir William Dunn School of Pathology to further develop the technology under the guidance of Dr. Paul Fairchild and Professor Herman Waldmann.